Does the use of a special (blue-green) colored light for removing bladder tumours help in increasing the rate amount of tumour detected in cases of bladder cancer ?
Phase 1
- Conditions
- Health Condition 1: null- Transitional Cell Carcinoma Bladder
- Registration Number
- CTRI/2015/03/005626
- Lead Sponsor
- Institutional Review Board Fluid research Grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 190
Inclusion Criteria
All patients who undergo Trans - urethral resection of bladder tumour (TURBT) in CMC Vellore from August 2013 to December 2014. New tumours and recurrent tumours (single or multiple tumours , largest tumour less than or equal to 5 cms in size) will both be included.
Diagnosis of bladder tumours will be made on the basis of cystoscopic
findings, imaging Ultrasonography (USG), Intravenous pyelogram (IVP) or
Computerized tomography (CT) or urine cytology.
Patients should be fit for anesthesia as decided by anesthetists.
Exclusion Criteria
Refused to consent
Size of tumour >5 cm
Other modality of treatment (Radiotherapy )
Not fit for anesthesia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Number of tumours detected by either modality: The pathologist will report the presence of malignancy, if detected, in both samples. The extra number of lesions, <br/ ><br>(tumours/ CIS), if reported, will be correlated to the type of light source used and will be used for statistical analysis. Negative reports will also be noted. <br/ ><br>2.Completeness of resectionTimepoint: The outcome will be assessed at the end of recruitment of all the patients required to complete the sample size (95 in each arm).
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI